These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33687549)

  • 1. Re-sleeping after reversal of remimazolam by flumazenil.
    Yamamoto T; Kurabe M; Kamiya Y
    J Anesth; 2021 Apr; 35(2):322. PubMed ID: 33687549
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risks.
    Masui K
    J Anesth; 2023 Feb; 37(1):1-5. PubMed ID: 36114320
    [No Abstract]   [Full Text] [Related]  

  • 4. Remimazolam should be antagonized by an adequate flumazenil.
    Sato T; Nishiwaki K
    J Anesth; 2023 Feb; 37(1):164-165. PubMed ID: 36197518
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting the amount of flumazenil needed to antagonize remimazolam.
    Aya D; Hoshi T; Yamaguchi H
    Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1335-1336. PubMed ID: 34581692
    [No Abstract]   [Full Text] [Related]  

  • 6. Simulation of residual sedation effect of remimazolam: pharmacokinetic-pharmacodynamic simulation can be an additional standard anesthesia monitoring method.
    Obara S
    J Anesth; 2022 Apr; 36(2):167-170. PubMed ID: 34160699
    [No Abstract]   [Full Text] [Related]  

  • 7. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of midazolam-induced laryngospasm with flumazenil.
    Davis DP; Hamilton RS; Webster TH
    Ann Emerg Med; 1998 Aug; 32(2):263-5. PubMed ID: 9701315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil.
    Curran HV; Birch B
    Psychopharmacology (Berl); 1991; 103(4):519-23. PubMed ID: 1676530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy.
    Worthington MT; Antonik LJ; Goldwater DR; Lees JP; Wilhelm-Ogunbiyi K; Borkett KM; Mitchell MC
    Anesth Analg; 2013 Nov; 117(5):1093-100. PubMed ID: 24108261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
    Hu Q; Liu X; Wen C; Li D; Lei X
    Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, controlled trial of cognitive and psychomotor recovery from midazolam sedation following reversal with oral flumazenil.
    Girdler NM; Lyne JP; Wallace R; Neave N; Scholey A; Wesnes KA; Herman C
    Anaesthesia; 2002 Sep; 57(9):868-76. PubMed ID: 12190751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flumazenil's reversal of myoclonic-like movements associated with midazolam in term newborns.
    Zaw W; Knoppert DC; da Silva O
    Pharmacotherapy; 2001 May; 21(5):642-6. PubMed ID: 11349753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
    Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
    Rex DK; Bhandari R; Desta T; DeMicco MP; Schaeffer C; Etzkorn K; Barish CF; Pruitt R; Cash BD; Quirk D; Tiongco F; Sullivan S; Bernstein D
    Gastrointest Endosc; 2018 Sep; 88(3):427-437.e6. PubMed ID: 29723512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen consumption after flumazenil reversal.
    Duvaldestin P; Lebrault C; Costes H; Barral N; Raimbault E
    Acta Anaesthesiol Scand; 1992 Aug; 36(6):592-4. PubMed ID: 1514349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.
    Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K
    Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observation of effective dosage of remimazolam tosilate used for moderate-to-deep sedation in fiberoptic bronchoscopy].
    Jia Z; Ren LX; Fan YT; Tan ZM
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):813-816. PubMed ID: 33765724
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy.
    Pastis NJ; Yarmus LB; Schippers F; Ostroff R; Chen A; Akulian J; Wahidi M; Shojaee S; Tanner NT; Callahan SP; Feldman G; Lorch DG; Ndukwu I; Pritchett MA; Silvestri GA;
    Chest; 2019 Jan; 155(1):137-146. PubMed ID: 30292760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.